Quantitative autofluorescence: Review of Current Technical Aspects and Applications in Chorioretinal Disease

Semin Ophthalmol. 2021 May 19;36(4):346-350. doi: 10.1080/08820538.2021.1908570. Epub 2021 Apr 4.

Abstract

Purpose: In this review we discuss the broad clinical application of qAF and provide a descriptive summary of the phenotypic findings of different chorioretinal pathologies.Background: Quantitative Fundus autofluorescence (qAF) is a novel developing technology that can aid in diagnosis and longitudinal disease monitoring by measuring and comparing autofluorescence intensities. Fundus autofluorescence (FAF) is a noninvasive imaging method that creates a density map of the fluorophores of the ocular fundus and provides both functional and topographic anatomic information about retinal cells. Fluorophores are molecules that have the ability to temporarily absorb irradiated light, and emit a small amount of light of a different wavelength. Different endogenous fluorophores can be found in the ocular fundus. Changes in accumulation of retinal fluorophores usually indicate retinal pathology and create characteristic patterns of hyper-autofluorescence and hypo-autofluorescence that help establish a diagnosis.Conclusion: qAF allows a safe non-invasive visualization of the retina, enables a standard for AF intensities comparison and aids to the understanding of the genotype-phenotype correlations.

Keywords: Quantitative fundus autofluorescence; age-related macular degeneration; chorioretinal disease; lipofuscin; retina.

Publication types

  • Review

MeSH terms

  • Fluorescein Angiography
  • Fundus Oculi
  • Humans
  • Optical Imaging*
  • Retina*